Wednesday, Mar 12, 2003

Genentech Appoints Philippa Norman Vice President, Global Supply Chain

South San Francisco, Calif. -- March 12, 2003 --

Genentech (NYSE: DNA) today announced the appointment of Philippa Norman to vice president, Global Supply Chain. Norman reports to David Ebersman, senior vice president, Product Operations.

In this role, Norman is responsible for Genentech's supply chain management organization and will oversee strategic planning for manufacturing in addition to directing inventory management, logistics, project management, contract manufacturing and manufacturing collaborations for the company.

"Philippa brings significant expertise and extensive industry knowledge to Genentech," said Ebersman. "I'm confident that her proven leadership ability combined with her prior work in supply chain management will enable her to succeed in managing this exciting and important aspect of our business."

Norman, 39, most recently served as vice president of Knowledge Acquisition at Ingenuity Systems. Prior to joining Ingenuity Systems, Norman spent nine years at SmithKline Beecham PLC in positions of increasing responsibility in supply chain strategy development, manufacturing management and global logistics, culminating as vice president and director of a network of 10 manufacturing facilities around the world. Early in her career, Norman worked at Eli Lilly & Co. and the Institute for Animal Health, both in the United Kingdom.

Norman received a Bachelor of Science degree in biochemistry from Warwick University and a Master of Business Administration degree from Warwick Business School in the United Kingdom.

Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for significant unmet medical needs. Fifteen of the currently approved biotechnology products originated from or are based on Genentech science. Genentech manufactures and commercializes ten biotechnology products directly in the United States. The company has headquarters in South San Francisco, California, and is traded on the New York Stock Exchange under the symbol DNA.

# # #